IRIS
ALBANO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.288
EU - Europa 7.292
AS - Asia 5.584
SA - Sud America 1.453
Continente sconosciuto - Info sul continente non disponibili 767
AF - Africa 317
OC - Oceania 4
Totale 30.705
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.824
SG - Singapore 2.274
DE - Germania 2.161
IT - Italia 1.766
CN - Cina 1.163
BR - Brasile 1.109
RU - Federazione Russa 951
HK - Hong Kong 706
SE - Svezia 634
GB - Regno Unito 560
VN - Vietnam 371
FR - Francia 341
FI - Finlandia 309
BD - Bangladesh 214
IN - India 199
CA - Canada 186
UA - Ucraina 149
CI - Costa d'Avorio 113
AR - Argentina 111
ID - Indonesia 109
IQ - Iraq 77
ZA - Sudafrica 71
MX - Messico 65
PK - Pakistan 64
CO - Colombia 59
JP - Giappone 58
PL - Polonia 57
TR - Turchia 50
VE - Venezuela 47
BE - Belgio 45
EC - Ecuador 45
LT - Lituania 45
NL - Olanda 42
PH - Filippine 39
CR - Costa Rica 38
ES - Italia 38
IE - Irlanda 37
AT - Austria 33
SA - Arabia Saudita 32
CL - Cile 29
SV - El Salvador 28
TN - Tunisia 28
MA - Marocco 27
CZ - Repubblica Ceca 25
GT - Guatemala 25
MY - Malesia 25
JM - Giamaica 24
UZ - Uzbekistan 24
NI - Nicaragua 21
HN - Honduras 20
PE - Perù 20
TT - Trinidad e Tobago 20
IL - Israele 19
JO - Giordania 19
NP - Nepal 19
KE - Kenya 15
PY - Paraguay 15
EG - Egitto 14
RO - Romania 14
CW - ???statistics.table.value.countryCode.CW??? 13
KZ - Kazakistan 13
ET - Etiopia 12
RS - Serbia 12
TH - Thailandia 12
BO - Bolivia 11
CH - Svizzera 11
AZ - Azerbaigian 10
KR - Corea 10
PT - Portogallo 10
IR - Iran 9
KG - Kirghizistan 9
AE - Emirati Arabi Uniti 8
PR - Porto Rico 8
AL - Albania 7
GP - Guadalupe 7
LB - Libano 7
PS - Palestinian Territory 7
SC - Seychelles 7
DK - Danimarca 6
GR - Grecia 6
BH - Bahrain 5
DZ - Algeria 5
HU - Ungheria 5
PA - Panama 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
DO - Repubblica Dominicana 4
GE - Georgia 4
HR - Croazia 4
MD - Moldavia 4
MU - Mauritius 4
OM - Oman 4
SN - Senegal 4
AM - Armenia 3
AU - Australia 3
BY - Bielorussia 3
CY - Cipro 3
EE - Estonia 3
HT - Haiti 3
MT - Malta 3
Totale 29.896
Salva come PNG Salva come JPEG
Città #
Ashburn 1.730
Fairfield 1.541
Singapore 1.198
San Jose 1.092
Woodbridge 898
Chandler 836
Houston 729
Hong Kong 700
Seattle 675
Milan 562
Cambridge 531
Nyköping 517
Wilmington 463
New York 415
Beijing 393
Council Bluffs 356
Ann Arbor 351
Jacksonville 313
Los Angeles 280
Lauterbourg 205
Rome 198
Lawrence 181
Roxbury 176
Helsinki 165
Bari 147
Dallas 147
Munich 134
Santa Clara 129
Boardman 119
Nanjing 117
Abidjan 112
Brooklyn 111
Ho Chi Minh City 111
Des Moines 106
São Paulo 100
Falkenstein 90
Princeton 83
Jakarta 79
Columbus 74
Buffalo 68
Hanoi 66
London 66
San Diego 65
Inglewood 63
Chicago 58
Moscow 56
Phoenix 53
Frankfurt am Main 52
Dong Ket 50
Tokyo 50
Atlanta 48
Figino 48
Paris 47
Montreal 46
Brussels 44
Warsaw 44
Naples 42
Redwood City 38
Rio de Janeiro 38
Denver 37
Nanchang 37
Turku 37
Nuremberg 36
Johannesburg 35
Dublin 33
San José 33
Belo Horizonte 30
North Bergen 30
Shenyang 30
Toronto 30
Baghdad 29
Chennai 29
The Dalles 29
Turin 28
Boston 27
Changsha 27
Jiaxing 27
Marseille 27
Dearborn 26
Dhaka 26
Tianjin 26
Vilnius 26
Orem 25
Pune 25
San Francisco 25
Bologna 24
Hebei 24
Mexico City 24
Brasília 23
Guangzhou 23
Shanghai 23
Tashkent 22
Managua 21
Guatemala City 19
Lahore 19
Mumbai 19
San Salvador 19
Washington 19
Poplar 18
Curitiba 17
Totale 18.290
Salva come PNG Salva come JPEG
Nome #
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 264
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 258
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome 244
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 230
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 229
Monosomal karyotype in myeloid neoplasias: a literature review 229
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA 221
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 221
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 221
A novel fusion 5'AFF3/3'BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma 220
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11) 219
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients 217
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 211
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy 210
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 209
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 207
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 207
A novel chromosomal translocation t(3;7)(q26;q21)in myeloid leukemia resulting in overexpression of EVI1 204
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 204
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 202
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 202
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 200
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 196
Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9) 194
Molecular cytogenetic study of instability at 1q21∼q32 in adult acute lymphoblastic leukemia 194
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1 191
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 190
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 189
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 187
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia 186
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 186
Non-treatment-related chronic myeloid leukemia as a second malignancy 182
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 182
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 180
Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases 179
t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene 178
Iron chelation therapy induces hematological response in transfusion dependent patient with myeloid malignancies 178
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma 178
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia 176
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment 175
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes 174
Decreased TET2 gene expression during chronic myeloid leukemia progression 173
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 173
Impact of bone marrow aspirate tregs on the response rate of younger newly diagnosed acute myeloid leukemia patients 173
FLAG-IDA REGIMEN AS SALVAGE THERAPY IN REFRACTORY/RELAPSED AML PATIENTS: A SINGLE-CENTER EXPERIENCE 171
Characterization of der(9) deletions in CML patients 170
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 170
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 170
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 169
Bone marrow ectopic expression of a non-coding RNA in childhood T-cell acute lymphoblastic leukemia with a novel t(2;11)(q11.2;p15.1) translocation 169
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 169
"Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia 168
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 168
Next-Generation Sequencing in Acute Lymphoblastic Leukemia 167
Concomitant occurrence of BCR-ABL and JAK2V617F mutation 166
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 166
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 166
Similar mechanisms formed ring markers containing chromosome 12 pericentromeric region in two patients with therapy-related acute myeloid leukemia 165
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 165
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 165
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements 164
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib 164
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints 162
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 161
Differences among young adults, adults, and elderly chronic myeloid leukemia patients. 161
Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick 161
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 160
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 159
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 158
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? 157
A rare case of IgM-Multiple Myeloma 157
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma 156
Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia 155
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 155
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience. 154
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 154
After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia 153
Analysis of percent identity of IGHV mutation as prognostic factor in CLL patients treated with fludarabine, cyclofosfamide and rituximab: a single centre experience 152
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 151
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia 150
FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients 150
Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link? 149
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 149
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a PH-positive chronic myeloid leukemia 148
Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia 148
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 147
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 147
SETBP1 dysregulation in congenital disorders and myeloid neoplasms 147
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients 145
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia 145
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile. 144
Submicroscopic deletions in an acute myelocytic leukemia case with a four-way t(8;11;16;21) 144
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases 144
Retinal abnormalities in newly diagnosed adult acute myeloid leukemia 144
Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia 143
Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors. 143
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. 143
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale 142
A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome 142
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP 141
Totale 17.576
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.062
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.093 0 0 0 0 65 132 70 58 122 124 223 299
2022/20232.244 308 307 157 153 228 315 38 270 347 11 49 61
2023/20241.070 79 138 56 58 106 406 24 43 5 29 17 109
2024/20254.090 152 68 263 178 156 339 509 352 185 251 560 1.077
2025/20269.544 1.177 402 613 1.027 1.117 541 1.010 280 1.056 927 305 1.089
2026/20272.694 294 460 560 1.185 195 0 0 0 0 0 0 0
Totale 30.705